Dr. Mouhssin Oufir
Mouhssin Oufir joined the research group in May 2010 coming from SGS Life Science Services (Wavre, Belgium), where he was a GLP Study Director in charge of bio-analytical support for preclinical and clinical studies in accordance with regulatory principles (OCDE and FDA GLPs) for two years. Mouhssin Oufir obtained a Master of Philosophy (M.Phil.) degree in Protein Engineering from the University of Nancy (France) in 1999 and a PhD in Biochemistry with Prof. emeritus B. Gutte and Prof. J. Schüpbach at the University of Zürich in 2004. After his degrees, he was a Research Scientist at the Biological Sciences Department within Heriot-Watt University (Edinburgh, UK) during one year and a bio-analytical responsible in an Environmental Research Center: CRP-Gabriel Lippmann (Belvaux, GD Luxembourg) for four years.
|Jähne, EA; Eigenmann, DE; Moradi-Afrapoli, F; Verjee, S; Butterweck, V; Hebeisen, S; Hettich, T; Schlotterbeck, G; Smiesko, M; Hamburger, M; Oufir, M: Caco-2 permeability studies and hERG liability assessment of tryptanthrin and indolinone, in: Planta Med. 82, 2016, S. 1192-1201.|
|Jähne, Evelyn A.; Sampath, Chethan; Butterweck, Veronika; Hamburger, Matthias; Oufir, Mouhssin: Development and full validation of an UPLC-MS/MS method for the quantification of indirubin in rat plasma, in: Journal of pharmaceutical and biomedical analysis 128, 2016, S. 247-52. edoc|
|Eigenmann, Daniela E.; Dürig, Carmen; Jähne, Evelyn A.; Smieško, Martin: In vitro blood-brain barrier permeability predictions of piperine analogues with GABAA receptor modulating properties, in: European journal of pharmaceutics and biopharmaceutics 103, 2016, S. 118-126. edoc|